Urethral Cancer
📧 Sign up to get email alerts when something new happens for Urethral Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors [Phase 2]
This clinical trial update outlines a Phase 2 study assessing the combination of nivolumab, ipilimumab, and cabozantinib for various rare ge…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors [Phase 1]
Phase 1 trial of bortezomib in combination with gemcitabine and doxorubicin for urothelial cancer and other solid tumors; the study is curre…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy [Phase 1]
A Phase 1 clinical trial is investigating the combination of Erdafitinib and Enfortumab Vedotin for metastatic bladder/urothelial cancers af…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer [Phase 1, Phase 2]
A study of Enfortumab Vedotin, alone or with other therapies, for urothelial cancers has been terminated.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: 64Cu-GRIP B in Patients With Advanced Malignancies [Phase 1, Phase 2]
Clinical trial update for a Phase 1/Phase 2 study of 64Cu-GRIP B in advanced malignancies, including prostate and renal cancers, which is cu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant [Phase 2]
Phase 2 clinical trial evaluating a four-drug combination—fluorouracil, leucovorin, gemcitabine, and cisplatin—for metastatic or unresectabl…
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: Afatinib in Advanced Refractory Urothelial Cancer [Phase 2]
Phase 2 trial of afatinib in advanced refractory urothelial cancer was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 trial results evaluate the combination of atezolizumab and CYT107 in participants with locally advanced, inoperable, or metastatic u…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer [Phase 1, Phase 2]
This update reports results from a Phase 1/2 trial evaluating ALT-801 in combination with cisplatin and gemcitabine in patients with muscle-…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium [Phase 3]
Phase 3 trial comparing two-drug vs four-drug chemotherapy regimens in advanced urothelial cancer (bladder cancer and related urothelial can…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy for advanced urothelial cancer with decreased kidney function has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract [Phase 2]
Phase 2 clinical trial evaluating piritrexim in advanced urinary tract cancers has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer [Phase 2]
Phase 2 trial evaluating docetaxel and gemcitabine in progressive regional or metastatic bladder cancer and related transitional cell cancer…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Combination Chemotherapy in Treating Patients With Bladder Cancer [Phase 3]
A Phase 3 clinical trial update on combination chemotherapy for bladder cancer and urethral cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract [Phase 2]
Phase 2 trial evaluating surgery plus combination chemotherapy and radiation therapy for cancer of the urinary tract (bladder cancer and rel…
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer [Phase 2]
Phase 2 clinical trial evaluating erlotinib hydrochloride in patients with muscle-invasive or recurrent urothelial cancer has completed, wit…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery [Phase 2]
Phase 2 clinical trial evaluating gemcitabine hydrochloride and eribulin mesylate in advanced or unresectable bladder, ureter, and urethral …
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer [Phase 2]
Phase 2 trial evaluating carboplatin and gemcitabine with or without vandetanib as first-line therapy for locally advanced or metastatic uri…
-
CLINICAL_TRIALS research · 2018-07-05Clinical Trial Update: Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
This clinical trial update reports on biomarker studies in patients with kidney cancer or urothelial cancers and in healthy participants.
-
CLINICAL_TRIALS trial_result · 2017-09-28Clinical Trial Update: Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma [Phase 3]
A Phase 3 trial comparing four vs six cycles of cisplatin-based chemotherapy in metastatic urothelial carcinoma is ongoing/unknown status.
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract [Phase 2]
Phase 2 SWOG trial of gemcitabine and paclitaxel in advanced or recurrent urinary tract cancers (bladder cancer, transitional cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium [Phase 1]
A Phase 1 trial from MD Anderson Cancer Center evaluated short-term low-dose interferon alfa in patients with urothelial cancers (bladder an…
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer [NA]
A completed trial compared videoscopic versus open inguinal lymphadenectomy for cancer. It includes melanoma and Merkel cell carcinoma among…
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium [Phase 2]
A Phase 2 trial evaluating VEGF Trap (aflibercept) in patients with recurrent, locally advanced, or metastatic urothelial cancers has comple…
-
CLINICAL_TRIALS withdrawal · 2014-01-29Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer [Phase 2]
This Phase 2 clinical trial evaluating gemcitabine plus cisplatin or a high-dose methotrexate/vinblastine/doxorubicin/cisplatin regimen for …